| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | Emster Kurt Von62 | Director | Sell | 72,934 | $29.85 | $2,176,898.24 | -3.0% | |
| Nov 21, 2018 | Celgene Corp /de/ | 10% Owner | Sell | 80,000 | $19.25 | $1,540,000.00 | -1.9% | |
| Jul 5, 2018 | Cagnoni Pablo J | Director | Sale+OE | 7,500 | $62.00 | $465,000.00 | -100% | |
| Jun 5, 2018 | Emster Kurt Von62 | Director | Sell | 920 | $12.51 | $11,509.20 | -4.8% | |
| Jun 1, 2018 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 15,000 | $69.36 | $1,040,400.00 | -4.7% | |
| May 17, 2018 | Novak Rodger75 | President | Sale+OE | 75,000 | $60.00 | $4,500,000.00 | -6.1% | |
| May 15, 2018 | Bolzon Bradley J Phd75 | Director | Sell | 44,000 | $57.99 | $2,551,440.00 | -3.3% | |
| May 15, 2018 | Woiwode Thomas | Director | Sell | 44,000 | $57.99 | $2,551,440.00 | -3.3% | |
| May 14, 2018 | Emster Kurt Von62 | Director | Sell | 650,000 | $54.39 | $35,352,455.99 | -4.7% | |
| May 8, 2018 | Woiwode Thomas | Director | Sell | 121,362 | $50.39 | $6,115,872.59 | -4.3% |